SCHEMBL20481952

SCHEMBL20481952

CC(C)CCC[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CC[C@H]1[C@]23OC3C=C2C[C@@H](O)CC[C@@]21C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR183 P32249 6/20 0.58
▸ RORC P51449 4/20 0.58
▸ RORA P35398 3/20 0.58
▸ NPC1L1 Q9UHC9 3/20 0.58
▸ PLA2G1B P04054 1/20 0.55
▸ MEN1 O00255 3/20 0.54
▸ KMT2A Q03164 3/20 0.54
▸ OSBP P22059 4/20 0.53
▸ USP2 O75604 3/20 0.53
▸ OSBP2 Q969R2 2/20 0.53
▸ LMNA P02545 1/20 0.53
▸ ABCB1 P08183 1/20 0.53
▸ CYP46A1 Q9Y6A2 1/20 0.53
▸ ALOX15 P16050 2/20 0.52
▸ CDC25A P30304 2/20 0.47
▸ CDC25B P30305 2/20 0.47
▸ NR1H3 Q13133 1/20 0.44
▸ GRIN1 Q05586 1/20 0.44
▸ GRIN2A Q12879 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20481953 1.00 GPR183 (0.58) GPR183RORCRORANPC1L1PLA2G1B
SCHEMBL22959587 1.00 GPR183 (0.58) GPR183RORCRORANPC1L1PLA2G1B
SCHEMBL18584449 1.00 GPR183 (0.58) GPR183RORCRORANPC1L1PLA2G1B
SCHEMBL18584451 1.00 GPR183 (0.58) GPR183RORCRORANPC1L1PLA2G1B
SCHEMBL18714203 0.80 RORC (0.62) GPR183RORCRORANPC1L1PLA2G1B
SCHEMBL18714205 0.80 RORC (0.62) GPR183RORCRORANPC1L1PLA2G1B
SCHEMBL13966714 0.80 RORC (0.62) GPR183RORCRORANPC1L1PLA2G1B
SCHEMBL25774172 0.78 RORC (0.59) GPR183RORCRORANPC1L1PLA2G1B
SCHEMBL6119630 0.78 RORC (0.59) GPR183RORCRORANPC1L1PLA2G1B
SCHEMBL27322122 0.77 RORC (0.56) GPR183RORCRORANPC1L1PLA2G1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4706644-A1 RECONSTITUTED HIGH-DENSITY LIPOPROTEIN NANOPARTICLES COMPRISING CHOLESTEROL Mepsgen Co., Ltd. (KR) 2026-03-11 — — EP claimed
WO-2024228596-A1 RECONSTITUTED HIGH-DENSITY LIPOPROTEIN NANOPARTICLES COMPRISING CHOLESTEROL (주) 멥스젠 2024-11-07 — — WO claimed
EP-4706644-A1 RECONSTITUTED HIGH-DENSITY LIPOPROTEIN NANOPARTICLES COMPRISING CHOLESTEROL Mepsgen Co., Ltd. (KR) 2026-03-11 — — EP disclosed
WO-2024228596-A1 RECONSTITUTED HIGH-DENSITY LIPOPROTEIN NANOPARTICLES COMPRISING CHOLESTEROL (주) 멥스젠 2024-11-07 — — WO disclosed
US-20210041466-A1 DIAGNOSTIC METHODS AND KITS CHOLESTENIX LTD (GB) 2021-02-11 — — US disclosed
EP-3345004-B1 DIAGNOSTIC METHODS AND KITS CHOLESTENIX LTD (GB) 2020-07-22 — — EP disclosed
US-20180246128-A1 DIAGNOSTIC METHODS AND KITS SWANSEA UNIVERSITY (GB) 2018-08-30 — — US disclosed
Send feedback